These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 33432947
1. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis via activating the PI3K/Akt pathway and suppressing the FoxO1 pathway in type 2 diabetes. Sun X, Cao Z, Ma Y, Shao Y, Zhang J, Yuan G, Guo X. Food Funct; 2021 Feb 15; 12(3):1207-1218. PubMed ID: 33432947 [Abstract] [Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, Chen Q, Li YH, Wang JJ, Kang YM, Zhu GQ. Clin Sci (Lond); 2015 Nov 15; 129(10):839-50. PubMed ID: 26201094 [Abstract] [Full Text] [Related]
3. Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubules. Kim JH, Ko HY, Wang HJ, Lee H, Yun M, Kang ES. Diabetes Obes Metab; 2020 Mar 15; 22(3):373-382. PubMed ID: 31692240 [Abstract] [Full Text] [Related]
4. Dapagliflozin attenuates renal gluconeogenic enzyme expression in obese rats. Swe MT, Thongnak L, Jaikumkao K, Pongchaidecha A, Chatsudthipong V, Lungkaphin A. J Endocrinol; 2020 May 15; 245(2):193-205. PubMed ID: 32092034 [Abstract] [Full Text] [Related]
7. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice. De Souza CT, Frederico MJ, da Luz G, Cintra DE, Ropelle ER, Pauli JR, Velloso LA. J Physiol; 2010 Jun 15; 588(Pt 12):2239-53. PubMed ID: 20421289 [Abstract] [Full Text] [Related]
10. Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice. Jia Y, He J, Wang L, Su L, Lei L, Huang W, Geng X, Zhang S, Meng X, Zhou H, Yang B. Cell Physiol Biochem; 2018 Jun 15; 45(5):1747-1758. PubMed ID: 29495021 [Abstract] [Full Text] [Related]
11. Jieduquyuziyin Prescription alleviates hepatic gluconeogenesis via PI3K/Akt/PGC-1α pathway in glucocorticoid-induced MRL/lpr mice. Ji LN, Wu S, Fu DQ, Fang SJ, Xie GQ, Fan YS, Bao J. J Ethnopharmacol; 2022 Feb 10; 284():114815. PubMed ID: 34763039 [Abstract] [Full Text] [Related]
18. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/ FoxO1/AKT/GSK3β signaling cascade. Ahmed SA, Sarma P, Barge SR, Swargiary D, Devi GS, Borah JC. Chem Biol Interact; 2023 Feb 01; 371():110347. PubMed ID: 36627075 [Abstract] [Full Text] [Related]